US 9546368
Methods for modulating metastasis-associated-in-lung-adenocarcinoma-transcript-1 (MALAT-1) expression
granted A61KA61K31/711A61P
Quick answer
US patent 9546368 (Methods for modulating metastasis-associated-in-lung-adenocarcinoma-transcript-1 (MALAT-1) expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jan 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/711, A61P, A61P35/00, A61P35/04